This is a pivotal trial. 187 pt w/ incomplete lupus (ANA+ plus 1-2 criteria, but not qualifying as SLE) shows that HCQ d

Tweet Author

Tweet Content

This is a pivotal trial. 187 pt w/ incomplete lupus (ANA+ plus 1-2 criteria, but not qualifying as SLE) shows that HCQ does not prevent progression to SLE! Congrats to these researchers lead by Nancy Olsen et al. https://t.co/NnrA8ohiGX

Links

https://twitter.com/ACR_Journals/status/1969025206405546234

August 29, 2025, FDA has terminated the Arthritis Advisory Committee, citing infrequent meetings & that the effort a

Tweet Author

RheumNow

Tweet Content

August 29, 2025, FDA has terminated the Arthritis Advisory Committee, citing infrequent meetings & that the effort and expense of maintaining the committee “is no longer justified.” The committee last met on 5/6/21 to review avacopan - that was subsequently approved. REALLY? https://t.co/w3Z6TszeWZ

Links

https://x.com/RheumNow/status/1968057322917249338/photo/1

19 September 2025

Did Hydroxychloroquine Reduce COVID-19 Mortality?

A multicenter study investigated the association between hydroxychloroquine (HCQ) dosage and COVID-19 mortality among hospitalized patients from multiple medical centers in China. The analysis focused on dose effects of HCQ on mortality.

This retrospective cohort includes 2,387 COVID-19 patients admitted to 12 hospitals in Hubei Province between January and June 2020. Patients are categorized into three groups: non-HCQ use (n=1,124), low-dose HCQ (≤600 mg/day, n=893), and high-dose HCQ (>600 mg/day, n=370). The primary endpoint is all-cause mortality.

Join us Sept 23 @ 7PM ET for the next Rheum to Breathe Journal Club! We’ll dive into two pivotal ILD studies: 📄 FI

Tweet Author

RheumNow

Tweet Content

Join us Sept 23 @ 7PM ET for the next Rheum to Breathe Journal Club! We’ll dive into two pivotal ILD studies: 📄 FIBRONEER (Nerandomilast in PPF) – NEJM 2025 📄 RECITAL (Rituximab vs Cyclophosphamide in CTD-ILD) – Lancet Panelists: Dr. Toby Maher, Dr. Shervin Assassi Moderator: https://t.co/l8EkX2hkLs

ILD and Mortality in Systemic Autoimmune Rheumatic Diseases Dr. Bryant England, Lincoln, NE, discusses interstitial lu

Tweet Author

RheumNow

Tweet Content

ILD and Mortality in Systemic Autoimmune Rheumatic Diseases Dr. Bryant England, Lincoln, NE, discusses interstitial lung disease and mortality in systemic autoimmune rheumatic diseases (SARDs), as part of RheumNow's Rheum to Breathe: ILD campaign, presented throughout the month https://t.co/wtg9Te6oth

18 September 2025

GLP-1 Drugs Reduce Rheumatoid Arthritis Symptoms

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved cardiovascular biomarkers, a small retrospective study indicated.

SARD-ILD and serious infection risk: The elephant in the room Interstitial lung disease (ILD) remains one of the large

Tweet Author

RheumNow

Tweet Content

SARD-ILD and serious infection risk: The elephant in the room Interstitial lung disease (ILD) remains one of the largest unmet clinical needs across many systemic autoimmune rheumatic diseases (SARD). ILD is highly prevalent across systemic sclerosis, mixed connective tissue https://t.co/oxIteGfUTd

Worsening Breathlessness in SSc ILD

QD Clinic: Application of the ACR CHEST Guidelines to Two Cases Dr. Sindhu Johnson, Toronto, discusses two cases that

Tweet Author

RheumNow

Tweet Content

QD Clinic: Application of the ACR CHEST Guidelines to Two Cases Dr. Sindhu Johnson, Toronto, discusses two cases that where the application of the ACR CHEST guidelines for the screening, monitoring and treatment of SSc-ILD and Rapidly Progressive ILD are applied, as part of https://t.co/ntW2WIvJ8c

CDC 2025–26 Updates to Influenza Vaccination. - Most are trivalent inactivated (IIV3s) or vaccines (RIV3), few live v

Tweet Author

RheumNow

Tweet Content

CDC 2025–26 Updates to Influenza Vaccination. - Most are trivalent inactivated (IIV3s) or vaccines (RIV3), few live virus(LAIV3) - FDA approved FluMist (LAIV3) for self-administration (ages 2-49) - If <18yrs, Flu vax should thimerosal free 2023/24 Flu vax prevented 7900 deaths, https://t.co/hjLBGKWNDr

Topics

This is a pivotal trial. 187 pt w/ incomplete lupus (ANA+ plus 1-2 criteria, but not qualifying as SLE) shows that HCQ d

August 29, 2025, FDA has terminated the Arthritis Advisory Committee, citing infrequent meetings & that the effort a

Join us Sept 23 @ 7PM ET for the next Rheum to Breathe Journal Club! We’ll dive into two pivotal ILD studies: 📄 FI

ILD and Mortality in Systemic Autoimmune Rheumatic Diseases Dr. Bryant England, Lincoln, NE, discusses interstitial lu

SARD-ILD and serious infection risk: The elephant in the room Interstitial lung disease (ILD) remains one of the large

Worsening Breathlessness in SSc ILD

QD Clinic: Application of the ACR CHEST Guidelines to Two Cases Dr. Sindhu Johnson, Toronto, discusses two cases that

CDC 2025–26 Updates to Influenza Vaccination. - Most are trivalent inactivated (IIV3s) or vaccines (RIV3), few live v

Do you get our email newsletter?